Previous 10 | Next 10 |
– Revenue of $1,013.1 Million Exceeds Guidance – – 5.2% Organic Constant Currency Revenue Growth ex. COVID-19, also Exceeding Guidance – Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30,...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2024 on Thursday, February 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time. The presentation and Q&A session will be webcast live and may be accessed through a link on the Inve...
2023-12-08 09:53:59 ET More on Hologic Hologic: Navigating The Covid Cliff Hologic, Inc. (HOLX) Q4 2023 Earnings Call Transcript Hologic: Post-Covid World Proving To Be A Nuisance On Profitability (Rating Downgrade) Hologic, KKR-backed Ajax Health develop lun...
2023-12-01 01:00:00 ET Hologic (NASDAQ: HOLX) stock price has staged a strong recovery in November after the company pointed to post-Covid-19 growth. The shares jumped to a high of $72.95, which was modestly higher than the year-to-date low of $64. It remains about 18% below the highest...
2023-11-30 08:20:51 ET Medtech firm Hologic ( NASDAQ: HOLX ) and KKR-backed Ajax Health have developed a new platform to detect lung cancer . Named Maverix Medical and managed by Ajax Health , the platform will develop and acquire innovative technologies and commercial ...
Platform Will Focus on Technologies to Detect Lung Cancer, the Leading Cause of Cancer Deaths KKR, a leading global investment firm, today announced a new platform established with investments from KKR and Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health and medica...
2023-11-27 13:13:29 ET U.S. President Joe Biden plans to invoke the Defense Production Act of 1950 to build up domestic production of essential drugs, as one of the many actions announced during the first meeting of his new supply chain resilience council. The Cold War-era federal l...
Leader in Women’s Health Will Highlight New Imaging Solutions That Aid in Cancer Detection and Radiologist Workflow Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109 th Scientific Assembly and Annual Meeting of t...
2023-11-21 13:46:19 ET Summary Today, we take a deeper look at diagnostic and medical device concern, Hologic, Inc., whose stock has made a nice run here in November. The company is seeing impressive growth from some of its core divisions, but overall sales are falling as demand f...
News, Short Squeeze, Breakout and More Instantly...
– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a privately held developer of breast cancer surgery technologies, for approximately $310 million, subject to working capital ...